Leading drug makers fared worse performances

Published: 2012-11-08 06:58:00

Updated: 2012-11-08 06:58:00

The country’s top-tier companies have struggled to find their feet during the nine months of the year, after a government-mandated price cut came into effect in April.

According to data released by Yakup.com, a pharmaceutical information provider, operating profits of industry bellwether Dong-...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK